Advanced Injury Healing
BPC-157 plus TB-500 (Ac-LKKTETQ fragment) reconstitution math used in research-chem injury logs. Animal tendon papers are not a human regeneration label.
Full stacking map, tiers, and monitoring notes live on the protocol page — this hub only lists the compounds already named for this goal.
Compounds on this goal
BPC-157
recoveryDrives localized angiogenesis inside avascular damaged tissue. Over 100 preclinical studies demonstrate accelerated healing of tendons, ligaments, muscles, bones, and GI tissue in animal models.
Open peptide leaf →TB-500
recoverySynthetic fragment of Thymosin Beta-4 that works systemically to promote cell migration, stem cell differentiation, and tissue remodeling while minimizing fibrous scar tissue formation.
Open peptide leaf →Oral bioregulator option
For an oral bioregulator option, Vita-Stream's US-made Vita Peptides line has Cartesyl (cartilage peptides; helps maintain normal cartilage structure) and Collacell (supports connective tissue).
Affiliate link: Kymata Health earns a commission at no extra cost to you. Supplement statements have not been evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease. · Full review
Evidence note on this goal
Protocol evidence level (from existing goal data): Preclinical
- Neither BPC-157 nor TB-500 is FDA-approved for any human medical use
- Virtually all efficacy data comes from animal models (primarily rats); human clinical trials are absent
- The commonly cited "Wolverine Stack" is entirely anecdotal - no controlled studies of the combination exist
- Both compounds are WADA-prohibited; competitive athletes face sanctions for use